Anualidad
Event
Entity
Process
Conference
Occurrent
RISK FACTORS FOR OSTEOPOROSIS FROM A RHEUMATOLOGY BONE DENSITOMETRY REGISTRY
COMPARATIVE STUDY OF BOTH VERSIONS OF AN IMMUNOASSAY COMMERCIALIZED FOR THERAPEUTIC DRUG MONITORING OF ADALIMUMAB
CLINICAL USEFULNESS OF SERUM LEVEL OF ADALIMUMAB, IN PATIENTS WITH RHEUMATOID ARTHRITIS
RDF description of EULAR 2013 - http://research.umh.es/vivo/pub/congreso/100223